Zealand Pharma A/S
ZLDPF
$77.42
-$1.78-2.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2,827.35% | -42.09% | -8.82% | -462.54% | 9.51% |
| Total Depreciation and Amortization | -3.18% | -12.76% | -0.88% | 48.78% | -47.72% |
| Total Amortization of Deferred Charges | -- | -- | 1,264.45% | -- | -- |
| Total Other Non-Cash Items | 2,286.30% | 162.28% | -177.01% | -29.50% | -64.26% |
| Change in Net Operating Assets | -1,192.39% | -3,707.33% | -49.60% | 90.72% | 84.63% |
| Cash from Operations | 3,982.45% | -116.90% | -400.20% | -164.41% | -29.94% |
| Capital Expenditure | -32.93% | -77.09% | 82.67% | 69.62% | -95.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,424.97% | 137.87% | 1,020.96% | -3,907.07% | 97.90% |
| Cash from Investing | -5,354.78% | 138.98% | 2,128.12% | -3,927.10% | 97.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.92% | -12.45% | 46.85% | -55.74% | 99.28% |
| Issuance of Common Stock | -99.62% | -99.76% | -99.45% | -23.99% | 366.44% |
| Repurchase of Common Stock | -310.23% | -- | -- | -- | -94.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 82.91% | -- | -196.08% |
| Cash from Financing | -104.84% | -100.04% | -181.44% | -6,913.23% | 667.93% |
| Foreign Exchange rate Adjustments | -18,757.00% | -178.04% | 151.65% | -137.49% | -24.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.18% | -78.24% | -146.87% | -11,912.59% | 1,371.79% |